Receive instant alerts when news is published about your stocks. Claim your one week free trial for StreetInsider Premium here.
ClearSign Technologies Corporation (Nasdaq: CLIR) today announced that it intends to sell its common stock in an underwritten public offering. All shares in the guaranteed public offering must be sold by ClearSign. ClearSign intends to grant the subscriber a 30-day option to purchase an additional 15% of the common shares offered in the public offering at the public offering price, less the underwriting discount. ClearSign intends to use the net proceeds from the offering for working capital, research and development, marketing and sales, and general corporate purposes. The final terms of the offer will depend on market and other conditions at the time of pricing, and there can be no assurance whether or not the offer will be completed, or as to the actual size or terms of the offer.
Newbridge Securities Corporation is acting as sole bookrunner for the offering.
The shares described above are offered by ClearSign pursuant to a shelf registration statement filed with and subsequently declared effective by the Securities and Exchange Commission (“SEC”). A preliminary prospectus supplement relating to the offering has been filed with the SEC and is available on the SEC’s website at http://www.sec.gov. A definitive prospectus supplement describing the terms of the offering will be filed with the SEC. The Offering will be made only by means of the Prospectus Supplement and the accompanying Base Prospectus, which may be supplemented by any free written prospectus and/or pricing supplement that the Company may file with the SEC. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, and there will be no sale of such securities in any state or jurisdiction in which a such offer, solicitation or sale would be unlawful. prior to registration or qualification under the securities laws of such state or territory. Copies of the preliminary prospectus supplement and base prospectus accompanying this offering may be obtained from Newbridge Securities Corporation, Attn: Equity Syndicate Department, 1200 North Federal Highway, Suite 400, Boca Raton, FL 33432, email: [email protected]phone: (877) 447-9625.